Status:
COMPLETED
Evaluation of a Brachytherapy Discharge Education Program to Improve Patient Care
Lead Sponsor:
University Health Network, Toronto
Conditions:
Gynecologic Cancer
Eligibility:
FEMALE
18-100 years
Phase:
NA
Brief Summary
Although brachytherapy is an effective treatment modality for gynecological cancer, a significant proportion of patients develop late treatment-related vaginal toxicity, negatively impacting their qua...
Detailed Description
Background: Brachytherapy is a type of radiation therapy used to treat patients with gynecological cancers. Brachytherapy delivers radiation to cancerous tissue by inserting or placing the radiation ...
Eligibility Criteria
Inclusion
- Scheduled to receive brachytherapy for treatment of gynecologic cancer at Princess Margaret Cancer Centre.
- Able to provide written informed consent
- Able to read and write in English
- \> 18 years of age
Exclusion
- Not receiving brachytherapy treatment
Key Trial Info
Start Date :
August 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 5 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04707937
Start Date
August 19 2020
End Date
December 5 2025
Last Update
December 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Cancer Centre
Toronto, Ontario, Canada, M5G 2M9